Cited by 955Autism Spectrum Disorder ResearchFolate and B Vitamins ResearchMetabolism and Genetic Disorders

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

Open access
James, S Jill, Cutler, Paul, Melnyk, Stepan, Jernigan, Stefanie, Janak, Laurette, Gaylor, David W, Neubrander, James A·2004·The American Journal of Clinical Nutrition

Abstract

Background Autism is a complex neurodevelopmental disorder that usually presents in early childhood and that is thought to be influenced by genetic and environmental factors. Although abnormal metabolism of methionine and homocysteine has been associated with other neurologic diseases, these pathways have not been evaluated in persons with autism.Objective The purpose of this study was to evaluate plasma concentrations of metabolites in the methionine transmethylation and transsulfuration pathways in children diagnosed with autism.Design Plasma concentrations of methionine, S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), adenosine, homocysteine, cystathionine, cysteine, and oxidized and reduced glutathione were measured in 20 children with autism and in 33 control children. On the basis of the abnormal metabolic profile, a targeted nutritional intervention trial with folinic acid, betaine, and methylcobalamin was initiated in a subset of the autistic children.Results Relative to the control children, the children with autism had significantly lower baseline plasma concentrations of methionine, SAM, homocysteine, cystathionine, cysteine, and total glutathione and significantly higher concentrations of SAH, adenosine, and oxidized glutathione. This metabolic profile is consistent with impaired capacity for methylation (significantly lower ratio of SAM to SAH) and increased oxidative stress (significantly lower redox ratio of reduced glutathione to oxidized glutathione) in children with autism. The intervention trial was effective in normalizing the metabolic imbalance in the autistic children.Conclusions An increased vulnerability to oxidative stress and a decreased capacity for methylation may contribute to the development and clinical manifestation of autism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/80.6.1611

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Children with ASD have higher levels of oxidised glutathione and F2-isoprostane than typically developing children.

    “Recent evidence shows that children with ASD have lower levels of total glutathion and glutathione peroxidase (an enzyme involved in antioxidant defense and detoxification), higher levels of oxidised glutathione and F2—isoprostane (a marker of oxidative stress and lipid peroxidation) and reduced capacity for methylation than typically developing children [16,153].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [153]

  • Children with ASD have reduced capacity for methylation than typically developing children.

    “Recent evidence shows that children with ASD have lower levels of total glutathion and glutathione peroxidase (an enzyme involved in antioxidant defense and detoxification), higher levels of oxidised glutathione and F2—isoprostane (a marker of oxidative stress and lipid peroxidation) and reduced capacity for methylation than typically developing children [16,153].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [153]

  • Children with ASD have lower levels of total glutathione and glutathione peroxidase than typically developing children.

    “Recent evidence shows that children with ASD have lower levels of total glutathion and glutathione peroxidase (an enzyme involved in antioxidant defense and detoxification), higher levels of oxidised glutathione and F2—isoprostane (a marker of oxidative stress and lipid peroxidation) and reduced capacity for methylation than typically developing children [16,153].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [153]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. White JF. Intestinal pathology in autism. Exp Biol Med (Maywood) 2003;228:639 -49.
  2. Baieli S, Pavone L, Meli C, Fiumara A, Coleman M. Autism and phe- nylketonuria. J Autism Dev Disord 2003;33:201-4.
  3. Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ. Homo- cysteine metabolism in children with Down syndrome: in vitro modu- lation. Am J Hum Genet 2001;69:88 -95.
  4. Gulati S, Brody LC, Banerjee R. Posttranscriptional regulation of mam- malian methionine synthase by B 12 . Biochem Biophys Res Comm 1999; 259:436 -42.

Cited by

Sorted by citations

Authors
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A.
Affiliations
Arkansas Children's Hospital (US)
Corresponding author
James, S Jill
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2004-12
Volume
80
Issue
6
Pages
1611-1617
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2112109116
Cited by
955
References
65
Citations by year
2026: 26 · 2025: 25 · 2024: 25 · 2023: 28 · 2022: 32 · 2021: 42 · 2020: 64 · 2019: 43 · 2018: 47 · 2017: 50 · 2016: 46 · 2015: 64 · 2014: 71 · 2013: 54 · 2012: 57
FWCI
12.91
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Rheumatology › Folate and B Vitamins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
autism spectrum disorder, oxidative stress, methionine metabolism, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine, glutathione, plasma metabolites, leucovorin, betaine, methylcobalamin, dietary intervention, children
MeSH terms
Adenosine, Autistic Disorder, Betaine, Child, Chromatography, High Pressure Liquid, Leucovorin, Cystathionine, Cysteine, Female, Glutathione, Homocysteine, Humans, Male, Methionine, Methylation, S-Adenosylhomocysteine, S-Adenosylmethionine, Vitamin B 12, Biomarkers, Case-Control Studies, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review